We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHX
1551
DELISTED
ChampionX
CHX
| $10.8M | ﹤0.01% |
319,854
-1,251,739
| -80% | -$34.1M |
|
1552
Monro
MNRO
$398M
| $10.8M | ﹤0.01% |
138,147
+349
| +0.3% | +$26.3K |
|
|
MAGN
1553
Magnera Corp
MAGN
$460M
| $10.8M | ﹤0.01% |
45,350
+9,800
| +28% | +$2.18M |
|
1554
Spectrum Brands
SPB
$2.07B
| $10.8M | ﹤0.01% |
167,505
+24,668
| +17% | +$1.4M |
|
1555
Fox Factory Holding Corp
FOXF
$886M
| $10.8M | ﹤0.01% |
154,604
-9,494
| -6% | -$613K |
|
1556
Douglas Dynamics
PLOW
$1.02B
| $10.7M | ﹤0.01% |
195,030
-21,278
| -10% | -$1.07M |
|
|
MGLN
1557
DELISTED
Magellan Health Services, Inc.
MGLN
| $10.7M | ﹤0.01% |
136,830
+22,916
| +20% | +$1.61M |
|
1558
Pinduoduo
PDD
$131B
| $10.7M | ﹤0.01% |
282,102
-2,548
| -0.9% | -$95.1K |
|
|
IBTX
1559
DELISTED
Independent Bank Group, Inc.
IBTX
| $10.6M | ﹤0.01% |
191,020
-1,978
| -1% | -$110K |
|
|
KAMN
1560
DELISTED
Kaman Corp
KAMN
| $10.6M | ﹤0.01% |
160,556
+45,439
| +39% | +$2.84M |
|
1561
Brown-Forman Class A
BF.A
$13.3B
| $10.6M | ﹤0.01% |
168,222
-18,053
| -10% | -$1.11M |
|
1562
Werner Enterprises
WERN
$2.25B
| $10.5M | ﹤0.01% |
289,795
-1,607
| -0.6% | -$58.8K |
|
1563
WD-40
WDFC
$3.15B
| $10.5M | ﹤0.01% |
54,184
-336
| -0.6% | -$63.3K |
|
1564
Glaukos
GKOS
$10.6B
| $10.5M | ﹤0.01% |
192,543
+15,009
| +8% | +$913K |
|
1565
Axsome Therapeutics
AXSM
$10.9B
| $10.5M | ﹤0.01% |
101,176
-2,383
| -2% | -$96.2K |
|
|
CSR
1566
Centerspace
CSR
$952M
| $10.4M | ﹤0.01% |
144,036
-2,500
| -2% | -$187K |
|
1567
Hawaiian Electric Industries
HE
$2.14B
| $10.4M | ﹤0.01% |
222,644
-15,246
| -6% | -$683K |
|
|
MODV
1568
DELISTED
ModivCare
MODV
| $10.4M | ﹤0.01% |
175,732
-8,713
| -5% | -$532K |
|
1569
ABM Industries
ABM
$2.84B
| $10.3M | ﹤0.01% |
274,340
-10,290
| -4% | -$384K |
|
|
DCPH
1570
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $10.3M | ﹤0.01% |
166,157
-136,104
| -45% | -$6.47M |
|
1571
WesBanco
WSBC
$4B
| $10.3M | ﹤0.01% |
272,958
-147,013
| -35% | -$5.49M |
|
1572
International Bancshares
IBOC
$4.57B
| $10.3M | ﹤0.01% |
239,393
-4,811
| -2% | -$199K |
|
1573
Cohen & Steers
CNS
$4.3B
| $10.3M | ﹤0.01% |
164,221
+59,892
| +57% | +$3.79M |
|
|
VRTU
1574
DELISTED
Virtusa Corporation
VRTU
| $10.3M | ﹤0.01% |
226,967
-157
| -0.1% | -$6.4K |
|
1575
H.B. Fuller
FUL
$3.28B
| $10.3M | ﹤0.01% |
199,093
-3,204
| -2% | -$159K |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.